- Home
- HSBC vs ABT Comparison
HSBC vs ABT Comparison
Compare HSBC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSBC
- ABT
- Stock Information
- Founded
- HSBC 1865
- ABT 1888
- Country
- HSBC United Kingdom
- ABT United States
- Employees
- HSBC N/A
- ABT N/A
- Industry
- HSBC Savings Institutions
- ABT Medical/Dental Instruments
- Sector
- HSBC Finance
- ABT Health Care
- Exchange
- HSBC Nasdaq
- ABT Nasdaq
- Market Cap
- HSBC 226.5B
- ABT 233.7B
- IPO Year
- HSBC N/A
- ABT N/A
- Fundamental
- Price
- HSBC $69.50
- ABT $134.56
- Analyst Decision
- HSBC Buy
- ABT Strong Buy
- Analyst Count
- HSBC 1
- ABT 19
- Target Price
- HSBC N/A
- ABT $143.68
- AVG Volume (30 Days)
- HSBC 1.3M
- ABT 4.9M
- Earning Date
- HSBC 10-28-2025
- ABT 10-15-2025
- Dividend Yield
- HSBC 4.72%
- ABT 1.75%
- EPS Growth
- HSBC N/A
- ABT 151.50
- EPS
- HSBC 1.00
- ABT 7.97
- Revenue
- HSBC $56,208,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- HSBC $11.26
- ABT $7.60
- Revenue Next Year
- HSBC $1.05
- ABT $7.84
- P/E Ratio
- HSBC $69.64
- ABT $16.89
- Revenue Growth
- HSBC N/A
- ABT 5.85
- 52 Week Low
- HSBC $43.72
- ABT $110.86
- 52 Week High
- HSBC $69.94
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- HSBC 69.77
- ABT 58.17
- Support Level
- HSBC $68.66
- ABT $130.96
- Resistance Level
- HSBC $69.94
- ABT $134.96
- Average True Range (ATR)
- HSBC 0.64
- ABT 2.47
- MACD
- HSBC 0.31
- ABT 0.18
- Stochastic Oscillator
- HSBC 93.11
- ABT 94.67
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.